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INTRODUCTION 
Presumptive treatment of uncomplicated febrile ill-
nesses with antimalarial drugs is a recommended policy 
in most sub-Saharan African countries where there is 
intense transmission of P. falciparum. 
The signs and symptoms of acute, uncomplicated ma-
laria are clinically indistinguishable from those of other 
common illnesses (1). Diagnostic accuracy can be im-
proved by determining the presence/absence of malaria 
parasites in the peripheral blood, but this approach re-
quires a microscope, supplies and trained microscopists. 
The costs of screening are commonly thought to exceed 
the costs of presumptive treatment (2,3), but this assump-
tion has not been tested in an adult outpatient setting in 
sub-Saharan Africa. 
We compared the cost of presumptive treatment of 
uncomplicated malaria in adult Malawians with the costs 
of microscopic screening followed by treatment directed 
only to those individuals who were parasitaemic. 
PATIENTS AND METHODS 
This study was carried out in the Outpatients Depart-
ment (OPD) of the Queen Elizabeth Central Hospital in 
Blantyre, Malawi. It consisted of four phases, each con-
ducted during the third week (Monday-Saturday) of four 
successive months (January-April) of the main malaria 
transmission season. 
Phase I: Daily tallies were made of all completed 
prescriptions in the OPD phaI'macy, noting the total 
number of prescriptions as well as the number of pre-
scriptions for antimalarial drugs. The normal OPD rou-
tine was not affected during this phase. 
Phase II: Phlebotomists and microscopists were 
placed in the OPD and thick blood films were prepared 
for all patients for whom antimalarial treatmen t had been 
prescribed (Sulphamethoxazole/Pyremethamine (S/P) 
and an antipyretic in 99%). Thick films were stained with 
Fields stains and read using a 100x oil immersion lens. 
Every tenth slide was read by another experienced mi-
croscopist who was unaware of the initial interpretation. 
Prescriptions were completed irrespective of the blood 
film results. Prescribers in the OPD were aware of the 
screening process. Daily tallies in the Pharmacy were 
made as described above. 
Phase III: Two weeks prior to Phase III, the results of 
Phase II were presented to the OPD prescribers in the 
context of a workshop on the clinical diagnosis of malaria. 
The process outlined for Phase II was then repeated and 
the effects of prescriber training were assessed. 
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£base IV: Procedures identical to Phases II and III 
were followed. OPD prescribers continued their usual 
practices, but the administration of specific antimalarial 
treatment (S/P, 3 tablets, stat, plus an antipyretic/analgesic) 
Has restricted to parasitaemic patients. Those who were 
aparasitaemic were seen again by a the Medical Director of 
the OPD and were treated with antipyretic/analgesic agents 
only. They were encouraged to return if their symptoms 
did not improve within 48-72 hours. 
RESULTS 
The results in each of the four phases are in Table I. 
Table 1. 
ToLal 
Scripts %AnU· Blood Blood Films % positive 
PHASE 
Scripts 
for AnLi· malarial 
Films 
posiLive Blood 
malarials Scripts for MPs Films 
I 7216 2883 39.9% - - -
II 5556 1171 21.1% 1174 344 29% 
III 7054 1480 21.0% 1005 353 35% 
IV 5377 357 6.6% 1170 347 30% 
Thefe were no statistically significant differences in the 
numbers of patients registered in the OPD (data not 
shown) or in the total number of prescriptions issued 
during Phases I, II, III and IV. 
The proportion of all prescriptions which was for anti-
malarial treatment was highest (40%) during Phase I, 
dropped significantly during Phases II and III (to 20%) and 
dropped even furtller (to 7%) during Phas~JV: There was 
no significant difference in this proportion between Phases 
II and III (before and after prescriber training). 
The proportion of patients presumptively diagnosed 
with malaria who were actually parasitemic was approxi-
mately 30% in Phases II, III and IV. The differences 
between phases was not statistically significant. 
Two MCE-level microscopists were able to manage the 
load generated each day. The discrepancies between 
their readings and those of other experienced microsco-
pists was 2%. 
COSTS OF MICROSCOPIC SCREENING 
1. Staff (schoolleavers, specially trained) 
a. Two microscopists (MCE) at K300/month 
x 12 1II0s/yr: K7200/yr 
b. One phleboLOmist aCE) at Kl50/month 
x 12 JIlos/yr: K1800/yr 
Total staff: K9000/yr 
2. Supplies (based on supplies consumed during Phases II-IV) 
COLLon wool K 41.00 
EtOH 6.63 




K321.03/3349 slides read 
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3. Annual cost of screening, assuming 1000 BFs/ week 
(@13l/BF= K 130/ week): 
K 130/ week x 52 = K 6760 (supplies) 
K 9000 (salaries) 
K15760 
COST SAVINGS WITH MICROSCOPIC SCREENING 
AND TREATMENT OF PARASITAEMIC PATIENTS 
ONLY 
In Phase I, we determined that 40% of all prescriptions 
were for antimalarial drugs. This proportion dropped to 
20% once the microscopists were placed in the OPD, but 
before receipt of antimalarial drugs was restricted to 
parasitaemic patients. The actual cost savings of micro-
scopic screening should be determined using the original 
40% figure. 
In Phase IV, we determined that directed treatment of 
parasitaemic patients only reduced the antimalarial propor-
tion of prescriptions dispensed to 7% of the total. The cost 
savings resulting from microscopic screening is the differ-
ence between the cost of providing antimalarials to 40% of 
the patients receiving prescriptions and the cost of provid-
ing antimalarials to only 7% of the patients receiving pre-
scriptions. (This may result in an underestimate of the 
savings, because it may be that in the "dry season", the 
proportion ofparasitaemic patients will be even lower.) 
The cost to the QECH Pharmacy for one adult treat-
ment dose of SIP (3 tablets) is 66 tambala. 
Assume that 6300 prescriptions are written each week 
in OPDs 1 and 2 (this is the average based on the four 
weeks of our study): 
Presumptive Rx: 6300 x 0.40 (40%)-
Directed Rx: 6300 x 0.07 (7%) • 
Drug cost savings: K1663.20 - K 291.06-
Less yearly cost of screening: 
TOTAL COST SAVINGS: 
2520 Rxs for SP 
x 66t/Rx 
K 1663.20/wk 
441 Rxs for SP 
x 66t/Rx 
K 291.06/ wk 
K 1372.14/week 




(2.7% of overall drug budget of K2,OOO,OOO/year) 
DISCUSSION 
This study demonstrates that, in the Queen Elizabeth 
Central Hospital out-patient setting, anti-malarial treat-
ment directed by the microscopic detection of malaria 
parasites is more cost effective (by 82%) than presumptive 
treatment of uncomplicated adult malaria. The pre-
dicted annual cost savings are the equivalent of the an-
nual yearly drug budget for the Dept of Orthopaedics 
(Chibwe RA, pers. comm.). 
Records of antibiotics dispensed from the pharmacy 
during Phases II-IV and the week immediately following 
each phase did not demonstrate an increase in antibiotic 
or other prescriptions during the study weeks. It is 
~erefore unlikely that more expensive "default" prescrip-
Uons would erode the cost savings realized by providing 
17 
anti-malarial drugs only for those patients who are parasi-
taemic. 
In malaria-endemic areas, individuals with acquired 
immunity to P. falciparum malaria may have malaria 
parasites in their blood and yet remain asymptomatic. 
Furthermore, since P. falciparum is only detectable in the 
peripheral blood for a portion of its life cycle, it is possible 
for an individual with malaria to be aparasitaemic at 
certain points during his/her infection. Therefore, a 
single negative blood film does not exclude the diagnosis 
~f malaria and a positive blood film does not necessarily 
Imply that the infected individual is ill because of his/her 
malaria infection. So, altl:!ough the addition of micros-
copy improves diagnostic accuracy, blood film results 
must be interpreted carefully. Because P. falciparum 
infections in adult Malawians are rarefy life-threatening, 
this degree of diagnostic uncertainty is acceptable. 
Young children. however, are at higher risk. of developing 
severe and complicated malaria and in this age group, a 
stronger argument for the presumptive treatment of 
malaria can be made. 
The degree of cost-savings depends upon the number 
of patients seen in any given setting, the proportion of 
those patients presumptively treated for malaria and the 
proportion of those presumptively treated who are 
parasitaemic and are thus recipients of directed treat-
ment. Using the figures determined in this study (40% 
of all prescriptions written for presumptive treatment, 
30% of those presumptively treated for malaria actually 
being parasitemic and thus receiving directed treatment), 
it is apparent that microscopic screening would be cost 
effective if more than one thousand patients are seen 
each week. 
In addition to the cost savings associated with directed 
treatment of malaria, there are several other benefits: 
1. Patients are spared the risks associated with the 
unnecessary administration of drugs. 
2. Antimalarial drugs are dispensed more judiciously, 
thus slowing the development of drug resistance. 
3. The pharmacy can monitor drug consumption 
more rigorously because a record can more easily 
be kept of patients "entitled" to receive antimalarial 
drugs. 
4. A mechanism will be in place for monitoring the 
evolution of drug resistance in a patient population. 
Patients treated with the recommended drug will be 
k.nown to have been parasitaemic upon initial re-
ceipt of the drug, and their blood film can be 
reche~ked if they fail to improve clinically. 
T~e findlI~gs of this study indicate that the cost savings 
asSOCiated wltll the directed treatment of malaria in the 
adult outpatients department of the Queen Elizabeth Cen-
tral Hospital are significant and justify reconsidering the 
policy of presumptive treatment of malaria in this setting. 
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